AbbVie and Pfizer return to the top of pharma's TV spending list for February

AbbVie and Pfizer return to the top of pharma's TV spending list for February

Source: 
Fierce Pharma
snippet: 

AbbVie’s Humira is back—at the top of the pharma TV ad spending pile, that is. In February, Humira was the No. 1 spender again, according to data from real-time TV ad tracker iSpot.tv, swapping places with Pfizer’s Xeljanz.